E. Androulakis

发表

Biological therapies targeting arrhythmias: are cells and genes the answer?

D. Tousoulis, R. Providência, D. Falconer, 2018, Expert opinion on biological therapy.

Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.

C. Stefanadis, D. Tousoulis, A. Kampoli, 2012, Current topics in medicinal chemistry.

Meta-Analysis of Oral Anticoagulants with Dual versus Single Antiplatelet Therapy in Patients after Percutaneous Coronary Intervention

D. Tousoulis, A. Briasoulis, N. Papageorgiou, 2016, American Journal of Cardiovascular Drugs.

Novel therapeutic strategies in the management of arterial hypertension.

C. Stefanadis, D. Tousoulis, N. Papageorgiou, 2012, Pharmacology & therapeutics.

Assessment of acute coronary syndromes: focus on novel biomarkers.

C. Stefanadis, D. Tousoulis, G. Siasos, 2012, Current medicinal chemistry.

Long-term Outcomes of Catheter Ablation for Ventricular Arrhythmias in Post-Myocarditis Patients: Insights from a Meta-Analysis of Current Data

Nikolaos S. Papageorgiou, G. Siasos, A. Briasoulis, 2022, SN Comprehensive Clinical Medicine.

Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nontarget Lesions in Patients With Diabetes Mellitus After Drug-Eluting Stent Implantation

G. Kolovou, I. Vasiliadis, E. Androulakis, 2016, Angiology.

Biomarkers in Essential Hypertension

D. Tousoulis, N. Papageorgiou, E. Androulakis, 2013 .

Genetic Variant of the C-reactive Protein Gene and Prevalence of Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus

C. Stefanadis, D. Tousoulis, A. Miliou, 2015 .

The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneys.

E. Lioudaki, E. Androulakis, J. Joslin, 2022, Reviews in cardiovascular medicine.

Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation.

G. Siasos, A. Briasoulis, C. Sohrabi, 2021, Reviews in cardiovascular medicine.

Renin‐Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta‐Analysis

T. Ando, A. Briasoulis, Tesfaye Telila, 2017, Journal of clinical hypertension.

Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.

I. Kallikazaros, C. Stefanadis, D. Tousoulis, 2013, American journal of hypertension.

Genetic polymorphism M235T of angiotensinogen: effects on endothelial function and arterial stiffness in hypertensives.

I. Kallikazaros, C. Stefanadis, D. Tousoulis, 2012, International journal of cardiology.

Lp-PLA2--a novel marker of atherosclerosis: to treat or not to treat?

C. Stefanadis, D. Tousoulis, N. Papageorgiou, 2013, International journal of cardiology.

Chronic thromboembolic pulmonary arterial hypertension: a review of the literature and novel therapeutic approaches

E. Lioudaki, Mahmood Ahmad, B. Schreiber, 2015, Expert review of respiratory medicine.

Inflammation and right ventricle: the hunting of the missing link.

C. Stefanadis, D. Tousoulis, C. Antoniades, 2013, International journal of cardiology.

Spontaneous Coronary Artery Dissection: Insights From Cardiac Magnetic Resonance and Extracoronary Arterial Screening.

D. Pennell, R. Mohiaddin, E. Androulakis, 2022, Circulation.

MicroRNAs in the diagnosis and treatment of unstable angina.

C. Stefanadis, D. Tousoulis, G. Siasos, 2013, Current Topics in Medicinal Chemistry.

Stable Angina Pectoris: Current Medical Treatment

C. Stefanadis, D. Tousoulis, G. Siasos, 2013 .

Heart rate as a therapeutic target in angina pectoris.

C. Stefanadis, D. Tousoulis, G. Siasos, 2013, Current pharmaceutical design.

Cardiopulmonary Exercise Physiology in AL Amyloidosis Patients with Cardiac Involvement and Its Association with Cardiac Imaging Parameters

M. Dimopoulos, A. Kallianos, G. Trakada, 2022, Journal of clinical medicine.

Cardiac Imaging and Management of Cardiac Disease in Asymptomatic Renal Transplant Candidates: A Current Update

I. Petrakis, E. Lioudaki, C. Bakogiannis, 2022, Diagnostics.

Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.

C. Stefanadis, G. Siasos, A. Kampoli, 2012, Current medicinal chemistry.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease

D. Tousoulis, C. Antoniades, N. Papageorgiou, 2015, Amino Acids.

Clinical utility of biomarkers in premature atherosclerosis.

C. Stefanadis, A. Kampoli, D. Tousoulis, 2012, Current medicinal chemistry.

The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure

D. Tousoulis, A. Briasoulis, E. Androulakis, 2016, Heart Failure Reviews.

Antioxidant treatment and endothelial dysfunction: is it time for flavonoids?

C. Stefanadis, D. Tousoulis, G. Siasos, 2013, Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery).

Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment.

D. Tousoulis, G. Siasos, E. Oikonomou, 2019, Current pharmaceutical design.

Multimodality Cardiac Imaging in Young and Veteran Athletes: Updates on Atrial Function Assessment, Arrhythmia Predisposition and Pathology Discrimination

E. Androulakis, F. Perone, 2023, Journal of clinical medicine.

The Role of microRNAs in Cardiovascular Disease

C. Stefanadis, D. Tousoulis, G. Siasos, 2012 .

Matrix metalloproteinases in acute coronary syndromes: current perspectives.

C. Stefanadis, D. Tousoulis, A. Kampoli, 2012, Current topics in medicinal chemistry.

Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: focus on the coagulation cascade and endothelial function.

C. Stefanadis, D. Tousoulis, A. Miliou, 2013, International journal of cardiology.

Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

D. Tousoulis, G. Siasos, A. Briasoulis, 2022, Journal of clinical medicine.

Novel Biomarkers Used in the Assessment of Acute Coronary Syndrome

D. Tousoulis, N. Papageorgiou, E. Androulakis, 2013 .

Inflammatory markers in essential hypertension: potential clinical implications.

C. Tsioufis, C. Stefanadis, D. Tousoulis, 2010, Current vascular pharmacology.

Genetic Polymorphisms and the Vascular Endothelium

C. Stefanadis, D. Tousoulis, E. Androulakis, 2015 .

Essential Hypertension: Is There a Role for Inflammatory Mechanisms?

Christodoulos Stefanadis, Dimitris Tousoulis, I. Kallikazaros, 2009, Cardiology in review.

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes

D. Tousoulis, G. Siasos, E. Lioudaki, 2017, Current cardiology reviews.

C-Reactive Protein in Cardiovascular Disease

D. Tousoulis, N. Papageorgiou, E. Androulakis, 2013 .

Biomarkers in Hyperlipidemia

D. Tousoulis, G. Siasos, E. Oikonomou, 2013 .

HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation

D. Tousoulis, A. Briasoulis, M. Charakida, 2016, Expert opinion on therapeutic targets.

Socioeconomic status and risk factors for cardiovascular disease: Impact of dietary mediators.

T. Psaltopoulou, D. Tousoulis, A. Briasoulis, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Fibrinogen and cardiovascular disease: genetics and biomarkers.

C. Stefanadis, D. Tousoulis, C. Antoniades, 2011, Blood reviews.

Coronary Artery Atherosclerosis in Hypertensive Patients: The Role of Fibrinogen Genetic Variability.

D. Tousoulis, G. Siasos, A. Miliou, 2017, Revista espanola de cardiologia.

Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives.

A. Briasoulis, S. Cornara, A. Somaschini, 2021, Reviews in cardiovascular medicine.

Pathophysiology of atherosclerosis: the role of inflammation.

C. Stefanadis, D. Tousoulis, K. Toutouzas, 2011, Current pharmaceutical design.

Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

C. Stefanadis, D. Tousoulis, G. Siasos, 2013, Journal of the American College of Cardiology.

Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment

T. Psaltopoulou, C. Stefanadis, D. Tousoulis, 2015, Cardiovascular Drugs and Therapy.

The Role of Cardiovascular Magnetic Resonance in Sports Cardiology; Current Utility and Future Perspectives

P. Swoboda, E. Androulakis, 2018, Current Treatment Options in Cardiovascular Medicine.

White-coat hypertension and cardiovascular events: a meta-analysis

D. Tousoulis, A. Briasoulis, N. Papageorgiou, 2016, Journal of hypertension.

Imaging Subclinical Atherosclerosis: Where Do We Stand?

D. Tousoulis, A. Briasoulis, N. Papageorgiou, 2016, Current cardiology reviews.

The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Myocardial Fibrosis in Young and Veteran Athletes: Insights From a Meta-Analysis

D. Mouselimis, A. Tsarouchas, C. Bakogiannis, 2021, Frontiers in Cardiovascular Medicine.

Interactions–Interrelationships Between Genetics and Environmental Factors in Cardiovascular Disease

E. Androulakis, T. Christophides, K. Norrington, 2016 .

Interrelation between heart failure with preserved ejection fraction and renal impairment.

E. Lioudaki, E. Androulakis, J. Joslin, 2022, Reviews in cardiovascular medicine.

Statins and myocardial infarction: Type, dose, and administration time: Does it matter?

D. Tousoulis, A. Briasoulis, N. Papageorgiou, 2016, Trends in cardiovascular medicine.

Hypertrophic cardiomyopathy or athlete’s heart? A systematic review of novel cardiovascular magnetic resonance imaging parameters

V. Vassilikos, D. Mouselimis, A. Tsarouchas, 2021, European journal of sport science.

Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonance.

R. Mohiaddin, A. Antonopoulos, E. Androulakis, 2021, European heart journal cardiovascular Imaging.

Inflammation in hypertension: current therapeutic approaches.

C. Tsioufis, C. Stefanadis, D. Tousoulis, 2011, Current pharmaceutical design.

Subclinical Organ Damage in White‐Coat Hypertension: The Possible Role of Cystatin C

I. Kallikazaros, D. Tousoulis, E. Lioudaki, 2017, Journal of clinical hypertension.

Magnetic resonance coronary angiography in the era of multimodality imaging.

K. Bratis, R. Mohiaddin, E. Androulakis, 2022, Clinical radiology.

Pacemaker Implantation following Heart Transplantation: Analysis of a Nation-Wide Database

A. Briasoulis, Bo Wu, E. Androulakis, 2023, Journal of clinical medicine.

Effects of the C-344T aldosterone synthase gene variant on preclinical vascular alterations in essential hypertension.

I. Kallikazaros, C. Stefanadis, D. Tousoulis, 2013, International Journal of Cardiology.

Effect of Training Load on Post-Exercise Cardiac Biomarkers in Healthy Children and Adolescents: A Systematic Review of the Existing Literature

A. Briasoulis, A. Xanthopoulos, E. Androulakis, 2023, Journal of clinical medicine.

Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management

K. Stylianou, I. Petrakis, E. Lioudaki, 2023, Journal of clinical medicine.

Improving the detection of preclinical organ damage in newly diagnosed hypertension: nocturnal hypertension versus non-dipping pattern

I. Kallikazaros, C. Stefanadis, D. Tousoulis, 2015, Journal of Human Hypertension.

Chylopericardium associated with constrictive pericarditis assessed by multimodality imaging

K. Bratis, V. Chandrasekaran, E. Androulakis, 2021, Clinical case reports.

The role of matrix metalloproteinases in essential hypertension.

C. Stefanadis, D. Tousoulis, G. Siasos, 2012, Current topics in medicinal chemistry.

Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease

D. Tousoulis, C. Antoniades, N. Papageorgiou, 2015, Amino Acids.

Essential Hypertension: Is There a Role for Inflammatory Mechanisms?

I. Kallikazaros, C. Tsioufis, C. Stefanadis, 2009, Cardiology in review.

Coronary Artery Atherosclerosis in Hypertensive Patients: The Role of Fibrinogen Genetic Variability.

D. Tousoulis, G. Siasos, A. Miliou, 2017, Revista espanola de cardiologia.

Stem cell-based therapies in cardiovascular diseases: from pathophysiology to clinical outcomes.

D. Tousoulis, M. Sagris, P. Theofilis, 2023, Current pharmaceutical design.

The role of patient-oriented mHealth interventions in improving Heart Failure outcomes: a systematic review of the literature.

P. Kampaktsis, C. Papadopoulos, D. Mouselimis, 2023, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Extracorporeal veno-venous ultrafiltration in patients with acute heart failure.

E. Lioudaki, S. Cornara, A. Somaschini, 2021, Reviews in cardiovascular medicine.

The role of microRNAs in cardiovascular disease.

C. Stefanadis, D. Tousoulis, G. Siasos, 2012, Current medicinal chemistry.

Assessment of extra-coronary peripheral arteriopathy in spontaneous coronary dissection: state of the art in non-invasive imaging techniques and future perspectives

R. Mohiaddin, E. Lioudaki, N. Kontopodis, 2023, European heart journal. Imaging methods and practice.